SEC Form 4 · accession 0001179110-16-018848

Editas Medicine, Inc. · EDIT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Boris Nikolic

Director

Period of report

Feb 8, 2016

Accepted (ET)

Feb 9, 2016 · 5:49 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001650664

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Feb 8, 2016	C	2,649,572	$0.00	A	2,649,572	I	See Footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series B Preferred Stock^F2,F1	—	Feb 8, 2016	C	6,888,888	A	—	—	Common Stock	2,649,572	0	I

Explanation of responses

F1The Series B Preferred Stock converted into Common Stock on a 2.6-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock wasconvertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
F2These shares are owned by bng0, LLC. Boris Nikolic, as a member and the managing director of bng0, LLC, has voting and investment power over such shares and may be deemed the indirect beneficial owner of such shares. Boris Nikolic disclaims beneficial ownership over such shares, except to the extent of any pecuniary interest therein.

Remarks

This report is one of two reports, each on a separate on Form 4 by bng0,LLC and Boris Nikolic, which relate to the same securities and the same transaction.